"10.1371_journal.pone.0137715","plos one","2015-09-18T00:00:00Z","Lucy Matthews; Shannon Kolind; Alix Brazier; Maria Isabel Leite; Jonathan Brooks; Anthony Traboulsee; Mark Jenkinson; Heidi Johansen-Berg; Jacqueline Palace","Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom; Neurology Department, Oxford University Hospitals NHS Trust, Oxford, United Kingdom; Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, Canada; Clinical Research and Imaging Centre (CRiCBristol), University of Bristol, Bristol, United Kingdom","Conceived and designed the experiments: LM SK MIL JB HJB JP. Performed the experiments: LM SK AB JB. Analyzed the data: LM SK AB JB MJ JP. Contributed reagents/materials/analysis tools: JB MJ. Wrote the paper: LM SK AB MIL JB AT MJ HJB JP.","Lucy Matthews has no relevant conflicts of interest. Shannon Kolind has received grants from Roche, personal fees from Roche, personal fees from Genzyme, personal fees from Serono, outside the submitted work. Alix Brazier has no relevant conflicts of interest. Maria Isabel Leite is involved in the AQP4 and MOG antibody testing, is supported by NHS National Specialised Commissioning Group for Neuromyelitis optica and by NIHR Oxford Biomedical Research Centre, and has received speaking honoraria from Biogen Idec, Japan, and travel and educational grant from Biogen Idec, UK. Dr. Traboulsee reports personal fees from Roche, personal fees from Teva Innovation, personal fees from EMD Serona, personal fees from Sanofi Genzyme, personal fees from Chugai Pharmaceuticals, personal fees from Medimmune, personal fees from Novartis, grants from Canadian Institute for Health Research, grants from Roche, grants from Sanofi Genzyme, outside the submitted work; Mark Jenkinson receives royalties from ISIS Innovation for FMRIB Software Library (FSL). Jonathan Brooks has no relevant conflicts of interest. Heidi Johansen-Berg receives royalties from Elsevier for edited volume Diffusion MRI. Jacqueline Palace has received support for scientific meetings and honoraria for advisory work from Merck Serono, Biogen Idec, Novartis, Teva, Chugai Pharma and Bayer Schering, and unrestricted grants from Merck Serono, Novartis, Biogen Idec and Bayer Schering. Her hospital trust receives funds for her role as clinical lead for the RSS, and she has received grants from the MS society for unrelated research studies. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","09","Lucy Matthews","LM",9,TRUE,6,4,6,9,TRUE,TRUE,FALSE,0,NA,FALSE
